You‐cai Zhu

Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells

Fengtao You, Licui Jiang, Bozhen Zhang et al. · Science China Life Sciences · 2016 · 148 citations · Full text

Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis

Kenny Kuchta, Yucheng Xiang, Shuai Huang et al. · Prostate Cancer and Prostatic Diseases · 2017 · 50 citations

Chemoprevention Strategy, Active Constituent, Medicine +6

The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel

Wu Zhuang, Junxun Ma, Xudong Chen et al. · Journal of Cancer · 2018 · 43 citations · Full text

Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs

C. Xu, Lei Lei, Wenxian Wang et al. · Translational Oncology · 2020 · 33 citations · Full text

EGFR-RAD51 fusion variant in lung adenocarcinoma and response to erlotinib: A case report

You‐cai Zhu, Wenxian Wang, C. Xu et al. · Lung Cancer · 2017 · 32 citations

Oncology, Egfr-rad51 Fusion Variant, Medicine +8